脂质修饰疗法与阻塞性睡眠呼吸暂停风险的关联:一种药物向的门德尔随机化研究
Juanjuan Zou1, Shengnan Qi2, Xiaojing Sun3
1Department of Otorhinolaryngology, Qilu Hospital of Shandong University, NHC Key Laboratory of Otorhinolaryngology (Shandong University), Jinan 250012, China; Medical Integration and Practice Center, Shandong University, Jinan 250012, China.
Toxicology and applied pharmacology
|March 23, 2024
概括
遗传分析表明,通过抑制胆固醇转移蛋白 (CETP) 来降低低密度脂蛋白胆固醇 (LDL-C) 可能会降低阻断性睡眠呼吸暂停 (OSA) 的风险. 这一发现凸显了OSA患者脂质管理的潜在作用.
科学领域:
- 遗传学 遗传学 是一个
- 心血管医学 心血管医学
- 睡眠医学 睡眠医学
背景情况:
- 阻塞性睡眠呼吸暂停 (OSA) 与失脂症有关.
- 有限的研究存在于脂质管理对OSA风险的影响.
研究的目的:
- 调查脂质修饰疗法与阻塞性睡眠呼吸暂停 (OSA) 风险之间的遗传关联.
主要方法:
- 一项针对药物的门德尔随机化 (MR) 研究使用全基因组关联研究 (GWAS) 总结数据进行.
- 分析包括脂质修饰药物标的cis变体和cis表达量特征位点 (eQTL).
- 主要分析使用了反变量加权 (IVW) 方法,通过加权中位数 (WM) 和MR-PRESSO进行灵敏度分析.
主要成果:
- 通过胆固醇转移蛋白 (CETP) 降低基因代理低密度脂蛋白胆固醇 (LDL-C) 与降低OSA风险相关 (OR=0.75).
- 在皮下脂肪组织,肺和小肠中的CETP表达显示出与OSA风险的显著MR关联.
- 没有发现HDL-C升高或降低甘油三的疗法与OSA风险有显著的关联.
结论:
- 这项研究提供了遗传证据,将通过CETP抑制的LDL-C降低疗法与OSA风险降低联系起来.
- 研究结果表明,在患有OSA的患者中,脂质管理策略可能发挥作用.
- 需要进一步的临床验证和机制研究.
相关概念视频
Management of Insomnia
244
The sleep cycle, an integral part of human health, consists of several stages with distinct characteristics and functions. It begins with a transition from wakefulness to sleep, known as the light sleep phase, followed by the restorative deep sleep phase, essential for physical recovery and growth. The cycle concludes with the Rapid Eye Movement (REM) phase, characterized by high brain activity and vivid dreaming. Insomnia, a prevalent sleep disorder, involves difficulty falling asleep, staying...
244
Antiasthma Drugs: Leukotriene Modifiers
291
Leukotriene modifiers, or cysteinyl leukotriene receptor antagonists, are medications used to manage chronic asthma. These agents target specific inflammatory mediators produced during arachidonic acid metabolism, an essential process in generating inflammation in the body.
Leukotriene modifiers work through two distinct mechanisms:
Leukotriene modifiers work through two distinct mechanisms:
291
Sedatives and Hypnotics Drugs: Miscellaneous Agents
171
Sedatives and hypnotics encompass a wide range of substances, each with its unique mechanism of action, uses, and potential adverse effects.
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
171
Lipid-Lowering Drugs: Statins and Miscellaneous Agents
659
Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
659
Insufficient Sleep and Sleep Deprivation
141
Insufficient sleep refers to not getting the recommended amount of sleep for optimal functioning, even if it's just slightly less than needed. Sleep insufficiency may occur due to lifestyle choices, such as staying up late for social events or work, resulting in routinely getting less sleep than required. For example, consistently sleeping 6 hours when the body needs 7-9 hours can lead to cumulative effects on health and well-being.
Sleep deprivation is a more severe form of sleep loss...
Sleep deprivation is a more severe form of sleep loss...
141
Overview of Lipid Metabolism
1.5K
Lipid metabolism is a crucial process in the human body that involves the synthesis and degradation of lipids. This process is essential for energy production, cell membrane formation, and hormone production, among other functions.
Lipolysis: The Breakdown of Lipids:
Lipolysis is the process of breaking down lipids, particularly triglycerides, into glycerol and fatty acids. This process typically occurs in the adipose tissue and is triggered by various hormones, including glucagon and...
Lipolysis: The Breakdown of Lipids:
Lipolysis is the process of breaking down lipids, particularly triglycerides, into glycerol and fatty acids. This process typically occurs in the adipose tissue and is triggered by various hormones, including glucagon and...
1.5K


